Thoratec to broaden circulatory support leadership with pump buy
This article was originally published in Clinica
Executive Summary
Thoratec has added to its portfolio of mechanical circulatory support products by purchasing catheter pump technology from Stockholm, Sweden-based Getinge for $8.5m in cash. Thoratec plans to use the technology in the development of a minimally-invasive acute cardiac axial flow pump. According to Thoratec’s president and CEO, Gary Burbach, there is an unmet need for fast and minimally-invasive acute cardiac support for haemodynamically unstable acute myocardial infarction, high-risk percutaneous coronary intervention and post-cardiotomy patients. “Given its potential ability to provide greater flow at a smaller size than other existing devices, we believe this technology offers the potential to be the basis for a breakthrough offering in this very significant market,” said Mr Burbach. Pleasanton, California-based Thoratec expects to incur incremental development costs linked to the deal of up to $3m in 2010.
You may also be interested in...
Alere aided by professional diagnostics sales in fourth quarter
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra and Stout to work on expandable interbody device
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe eyes portfolio expansion to help boost molecular diagnostics credentials
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals